Development of a dissolution method for lumefantrine and artemether in immediate release fixed dose artemether/lumefantrine tablets

被引:8
|
作者
Belew, Sileshi [1 ,2 ,3 ]
Suleman, Sultan [1 ,2 ]
Duguma, Markos [1 ,2 ]
Teshome, Henok [1 ,2 ]
Wynendaele, Evelien [3 ]
Duchateau, Luc [4 ]
De Spiegeleer, Bart [3 ]
机构
[1] Jimma Univ, Lab Drug Qual JuLaDQ, POB 378, Jimma, Ethiopia
[2] Jimma Univ, Sch Pharm, POB 378, Jimma, Ethiopia
[3] Univ Ghent, Fac Pharmaceut Sci, Drug Qual & Registrat DruQuaR Grp, Ottergemsesteenweg 460, B-9000 Ghent, Belgium
[4] Univ Ghent, Fac Vet Med, Biometr Res Grp, Salisburylaan 133, B-9820 Merelbeke, Belgium
关键词
Artemether; Dissolution; In-vitro; Lumefantrine; PHYSICOCHEMICAL PROPERTIES; FALCIPARUM-MALARIA; CLASSIFICATION; SOLUBILITY; SURFACTANT; PROFILES; DRUGS;
D O I
10.1186/s12936-020-03209-5
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background Dissolution of artemether (ART) and lumefantrine (LUM) active pharmaceutical ingredients (APIs) in fixed dose combination (FDC) ART/LUM tablets is one of the critical quality attributes. Thus, the verification of the release profile of ART and LUM from FDC ART/LUM tablets using a robust and discriminatory dissolution method is crucial. Therefore, the aim of this study was to develop and validate an appropriate dissolution method for quality control of FDC ART/LUM tablets. Methods The dissolution medium was selected based on saturation solubility data and sink conditions. The effect of agitation speed, pH and surfactant concentration on the release of ART and LUM was evaluated by employing a two-level factorial experiment. The resulting final method was validated for linearity, precision, robustness and API stability. In addition, the discriminatory power of the method was evaluated using expired and unexpired FDC ART/LUM products. Results A suitable dissolution profile of FDC ART/LUM tablets was obtained in 900 ml HCl (0.025 N, pH 1.6) with 1%Myrj 52 using paddle method at 100 rpm and 37 degrees C. ART and LUM were analysed using a HPLC method with UV detection at wavelengths of 210 and 335 nm, respectively. The results from the stability study showed that ART and LUM were sufficiently stable in HCl (0.025 N, pH 1.6) with 1%Myrj 52 at 37 degrees C. The method was linear (r(2) = 0.999) over the concentration range of 6.25-100 mu g/ml. The results for precision were within the acceptance limit (%RSD < 2). The percent relative standard deviation (< 2%) and statistically non-significant (p > 0.05) difference in release of ART and LUM observed between deliberately changed dissolution method settings (pH = 1.6 +/- 0.2 or agitation speed = 100 +/- 2) and optimized dissolution conditions revealed the robustness of the dissolution method. The method was capable to discriminate among different FDC ART/LUM products with different quality. Conclusions The developed dissolution method is robust and discriminatory. It can be used in the quality evaluation of FDC ART/LUM tablets.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Development of a dissolution method for lumefantrine and artemether in immediate release fixed dose artemether/lumefantrine tablets
    Sileshi Belew
    Sultan Suleman
    Markos Duguma
    Henok Teshome
    Evelien Wynendaele
    Luc Duchateau
    Bart De Spiegeleer
    Malaria Journal, 19
  • [2] Development and Validation of a Dissolution Test Method for Artemether and Lumefantrine in Tablets
    Umapathi, P.
    Ayyappan, J.
    Quine, S. Darlin
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2011, 10 (05) : 643 - 653
  • [3] Simultaneous determination of artemether and lumefantrine in fixed dose combination tablets by HPLC with UV detection
    Cesar, Isabela da Costa
    Andrade Nogueira, Fernando Henrique
    Pianetti, Gerson Antonio
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2008, 48 (03) : 951 - 954
  • [4] Quality of fixed dose artemether/lumefantrine products in Jimma Zone, Ethiopia
    Sileshi Belew
    Sultan Suleman
    Tesfaye Mohammed
    Yimer Mekonnen
    Markos Duguma
    Henok Teshome
    Bikila Bayisa
    Evelien Wynendaele
    Matthias D’Hondt
    Luc Duchateau
    Bart De Spiegeleer
    Malaria Journal, 18
  • [5] Quality of fixed dose artemether/lumefantrine products in Jimma Zone, Ethiopia
    Belew, Sileshi
    Suleman, Sultan
    Mohammed, Tesfaye
    Mekonnen, Yimer
    Duguma, Markos
    Teshome, Henok
    Bayisa, Bikila
    Wynendaele, Evelien
    D'Hondt, Matthias
    Duchateau, Luc
    De Spiegeleer, Bart
    MALARIA JOURNAL, 2019, 18 (1)
  • [6] A Simple and Sensitive HPTLC Method for Quantitative Analysis of Artemether and Lumefantrine in Tablets
    Pawan K. Saini
    Raman M. Singh
    Satish C. Mathur
    Gyanendra N. Singh
    Chhoten L. Jain
    Roop K. Khar
    Abdul Hafeez
    JPC – Journal of Planar Chromatography – Modern TLC, 2010, 23 : 119 - 122
  • [7] A Simple and Sensitive HPTLC Method for Quantitative Analysis of Artemether and Lumefantrine in Tablets
    Saini, Pawan K.
    Singh, Raman M.
    Mathur, Satish C.
    Singh, Gyanendra N.
    Jain, Chhoten L.
    Khar, Roop K.
    Hafeez, Abdul
    JPC-JOURNAL OF PLANAR CHROMATOGRAPHY-MODERN TLC, 2010, 23 (02) : 119 - 122
  • [8] Level A in vitro-in vivo correlation: Application to establish a dissolution test for artemether and lumefantrine tablets
    Rivelli, Graziella Gomes
    Magalhaes Ricoy, Leticia Brandao
    Cesar, Isabela Costa
    Fernandes, Christian
    Pianetti, Gerson Antonio
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2018, 155 : 262 - 269
  • [9] Clinical pharmacokinetics of artemether and lumefantrine (Riamet®)
    Lefèvre G.
    Thomsen M.S.
    Clinical Drug Investigation, 1999, 18 (6) : 467 - 480
  • [10] Artemether-Lumefantrine: An Option for Malaria
    Stover, Kayla R.
    King, S. Travis
    Robinson, Jessica
    ANNALS OF PHARMACOTHERAPY, 2012, 46 (04) : 567 - 577